Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on Thursday, June 21st | ||
By: Nasdaq / GlobeNewswire - 20 Jun 2018 | Back to overview list |
|
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced participating in an upcoming panel in New York City.
A live audio webcast of the panel discussion will be accessible from Keryx’s website at http://investors.keryx.com within the Investor Relations section under “events and presentations.” An archived version of the webcast will be available for at least 15 days following the conclusion of the panel discussion. About Keryx Biopharmaceuticals, Inc. CONTACT: KERYX BIOPHARMACEUTICALS CONTACT Amy Sullivan Senior Vice President, Corporate Affairs T: 617.466.3519 amy.sullivan@keryx.com |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |